The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Hepatic stellate cells (HSCs) known as “master producers” and macrophages as “master regulators”, are the key cell types that strongly contribute to the progression of liver fibrosis. Since Notch signaling regulates multiple cellular processes, we aimed to study the role of Notch signaling in HSCs differentiation and macrophages polarization and to evaluate its implication in liver fibrogenesis. Notch pathway components were found to be significantly upregulated in TGFβ-activated HSCs, inflammatory M1 macrophages and in mouse and human fibrotic livers. Interestingly, inhibition of Notch using a selective γ-secretase inhibitor, Avagacestat, significantly inhibited TGFβ-induced HSC activation and contractility and suppressed M1 macrophages. Additionally, Avagacestat inhibited M1 driven-fibroblasts activation and fibroblasts-driven M1 polarization (nitric oxide release) in fibroblasts and macrophages co-culture and conditioned medium studies. In vivo , post-disease treatment with Avagacestat significantly attenuated fibrogenesis in CCl 4 -induced liver fibrosis mouse model. These effects were attributed to the reduction in HSCs activation and inhibition of inflammatory M1 macrophages and upregulation of suppressive M2 macrophages. These findings suggest that Notch signaling plays a crucial role in HSC activation and M1/M2 polarization of macrophages in liver fibrosis. These results provide new insights for the development of novel therapies against liver fibrosis through modulation of Notch signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bansal et al. (5) showed that components of the Notch signaling pathway -key mediators of cell-cell communication- are upregulated in HSCs, the principal effectors of fibrogenesis, as well as in pro-fibrotic macrophages in both murine and human livers.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Avagacestat also promoted deactivation of human LX2 cells, an established HSC cell line.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Pharmacological inhibition of Notch signaling using avagacestat, a selective γ-secretase inhibitor, attenuated fibrosis and increased the abundance of pro-resolutive macrophages.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [5]
In the citing paper
“Notch signaling has been identified as an important driver of HSC activation in fibrosis in general (114, 153).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 1×
“Additionally, hepatic immunological environment determines the functional plasticity of macrophages varied from classical inflammatory M1 macrophages to alternatively differentiated restorative M2 macrophages 12,29 .”
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 3×
“response is predominantly mediated by classically-activated (M1-differentiated) macrophages (activated by Th1 cytokines e.g. IFN-γ , LPS, TNF-α or IL-12) 10–12 .”
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643 · cited 4×
“Interaction between Notch receptor-and Notch ligand-expressing cells leads to the activation of Notch signaling cascade resulting in the cleavage of ligand-activated Notch receptor by γ -secretase complex 21 .”
InfluentialHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“Owing to liver fibrogenesis, quiescent HSCs become activated to a contractile myofibroblast-like matrix-secreting phenotype and secrete fibrillar colla-gens resulting in deposition of fibrotic matrix and scar-tissue formation 6 .”
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“Hepatic stellate cells (HSCs) are considered as the major producers of fibrotic ECM during liver fibrosis, but activation of macrophages is also an essential step in the initiation of fibrogenesis and they are signified as positive modulators of fibrosis 25–27 .”
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061
Notch signaling: simplicity in design, versatility in function
Andersson, E. R., Sandberg, R., & Lendahl, U. (2011) · Development · doi:10.1242/dev.063610 · Cited by 950
Pathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894 · cited 1×
“Therefore, modulation or inhibition of HSC activation is a promising approach to treat fibrotic diseases 28 .”
Hepatic fibrosis: concept to treatment
Trautwein, C., Friedman, S. L., Schuppan, D., & Pinzani, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.039 · Cited by 677
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613
Notch Signaling in Development and Cancer
Bolós, V., Grego-Bessa, J., & de la Pompa, J. L. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0046 · Cited by 545
Wang, Y.-C., He, F., Feng, F., Liu, X.-W., Dong, G.-Y., Qin, H.-Y., Hu, X.-B., Zheng, M.-H., Liang, L., Feng, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0269 · Cited by 475 · cited 2×
“…deposition and their contractility suggesting the crucial role of Notch pathway in the differentiation and activation of HSCs. Previously, it has been shown that Notch signaling is critically involved in LPS-induced macrophage activation and macrophage plasticity in cancer and autoimmunity 34–37 .”
Xu, H., Zhu, J., Smith, S., Foldi, J., Zhao, B., Chung, A. Y., Outtz, H., Kitajewski, J., Shi, C., Weber, S., et al. (2012) · Nature Immunology · doi:10.1038/ni.2304 · Cited by 438
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Sica, A., Invernizzi, P., & Mantovani, A. (2014) · Hepatology · doi:10.1002/hep.26754 · Cited by 422 · cited 4×
“response is predominantly mediated by classically-activated (M1-differentiated) macrophages (activated by Th1 cytokines e.g. IFN-γ , LPS, TNF-α or IL-12) 10–12 .”
InfluentialShi-Wen, X., Chen, Y., Denton, C. P., Eastwood, M., Renzoni, E. A., Bou-Gharios, G., Pearson, J. D., Dashwood, M., du Bois, R. M., Black, C. M., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-12-0902 · Cited by 356
Friedman, S. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.013 · Cited by 350
Bielesz, B., Sirin, Y., Si, H., Niranjan, T., Gruenwald, A., Ahn, S., Kato, H., Pullman, J., Gessler, M., Haase, V. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43025 · Cited by 345
Shi, Z., Wakil, A. E., & Rockey, D. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10663 · Cited by 310
Notch signaling in development and disease
Hansson, E. M., Lendahl, U., & Chapman, G. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.011 · Cited by 258
Emerging roles of Notch signaling in liver disease
Geisler, F., & Strazzabosco, M. (2015) · Hepatology · doi:10.1002/hep.27268 · Cited by 249
NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation
Xu, J., Chi, F., Guo, T., Punj, V., Lee, W. N. P., French, S. W., & Tsukamoto, H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76468 · Cited by 241 · cited 1×
“Some studies have shown enhanced M1 gene expression and pro-inflammatory responses owing to the activation of Notch pathway 33,34 .”
Notch and disease: A growing field
Louvi, A., & Artavanis-Tsakonas, S. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.005 · Cited by 192
Monocytes and Macrophages as Cellular Targets in Liver Fibrosis
Heymann, F., Trautwein, C., & Tacke, F. (2009) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152809789352230 · Cited by 189
Imamura, M., Ogawa, T., Sasaguri, Y., Chayama, K., & Ueno, H. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.005 · Cited by 177 · cited 1×
“Hepatic stellate cells (HSCs) are considered as the major producers of fibrotic ECM during liver fibrosis, but activation of macrophages is also an essential step in the initiation of fibrogenesis and they are signified as positive modulators of fibrosis 25–27 .”
Zhang, W., Xu, W., & Xiong, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904016 · Cited by 177
Notch1 upregulates LPS‐induced macrophage activation by increasing NF‐κB activity
Monsalve, E., Ruiz‐García, A., Baladrón, V., Ruiz‐Hidalgo, M. J., Sánchez‐Solana, B., Rivero, S., García‐Ramírez, J. J., Rubio, A., Laborda, J., & Díaz‐Guerra, M. J. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200838722 · Cited by 152
Cell–cell signaling in co-cultures of macrophages and fibroblasts
Holt, D. J., Chamberlain, L. M., & Grainger, D. W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.101 · Cited by 143 · cited 1×
“Cross-talk between macrophages and fibroblasts (or stellate cells) drives fibrogenic process via juxtacrine (cell-cell contact) or paracrine (non-cell contact) signaling pathways 40 .”
Inhibition of Notch Signaling by a γ-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats
Chen, Y., Zheng, S., Qi, D., Zheng, S., Guo, J., Zhang, S., & Weng, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046512 · Cited by 139
Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options
Gressner, O. A., Weiskirchen, R., & Gressner, A. M. (2007) · Comparative Hepatology · doi:10.1186/1476-5926-6-7 · Cited by 137
Ectopic SOX9 Mediates Extracellular Matrix Deposition Characteristic of Organ Fibrosis
Piper Hanley, K., Oakley, F., Sugden, S., Wilson, D. I., Mann, D. A., & Hanley, N. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707390200 · Cited by 120 · cited 1×
“In addition, we observed that SRY (sex determining region Y)-box 9 (SOX9), that regulates collagen expression during organ fibrogenesis, that is also regulated by Notch signaling pathway 23,24 , was significantly increased in fibrotic mice as compared to control mice.”
Nijjar, S. S., Crosby, H. A., Wallace, L., Hubscher, S. G., & Strain, A. J. (2001) · Hepatology · doi:10.1053/jhep.2001.29399 · Cited by 106
Shi, C., Washington, M. K., Chaturvedi, R., Drosos, Y., Revetta, F. L., Weaver, C., Buzhardt, E., Yull, F. E., Blackwell, T. S., Sosa‐Pineda, B., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.10 · Cited by 88 · cited 1×
“Since fibrogenesis is a dynamic process tightly regulated by macrophage-stellate cells interaction 38,39 .”
Activated Hepatic Stellate Cells Mediate the Differentiation of Macrophages
Chang, J., Hisamatsu, T., Shimamura, K., Yoneno, K., Adachi, M., Naruse, H., Igarashi, T., Higuchi, H., Matsuoka, K., Kitazume, M. T., et al. (2013) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01111.x · Cited by 56 · cited 1×
“Since fibrogenesis is a dynamic process tightly regulated by macrophage-stellate cells interaction 38,39 .”
Zhu, F., Tang, L., Qiu, F., Fan, J., Zhou, Q., Ding, X., Nie, J., & Yu, X. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090447 · Cited by 52
Morphogens and hepatic stellate cell fate regulation in chronic liver disease
Tsukamoto, H., Zhu, N., Wang, J., Asahina, K., & Machida, K. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07022.x · Cited by 37 · cited 1×
“During fetal development and liver regeneration, several highly conserved signaling pathways (Wnt, Hedgehog and Notch) are utilized that orchestrate organogenesis 14 .”
Hosokawa, S., Furuyama, K., Horiguchi, M., Aoyama, Y., Tsuboi, K., Sakikubo, M., Goto, T., Hirata, K., Tanabe, W., Nakano, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep08518 · Cited by 35
Guo, L., Enzan, H., Hayashi, Y., Miyazaki, E., Jin, Y., Toi, M., Kuroda, N., & Hiroi, M. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.07.006 · Cited by 22 · cited 1×
“Since HSCs and macrophages are the key cells in the fibrous areas 22 , we investigated the activation of Notch pathway activation in these cells in vitro .”
Cited by
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Zhu, C., Kim, K., Wang, X., Bartolome, A., Salomao, M., Dongiovanni, P., Meroni, M., Graham, M. J., Yates, K. P., Diehl, A. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0344 · Cited by 250
Tanwar, S., Rhodes, F., Srivastava, A., Trembling, P. M., & Rosenberg, W. M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i2.109 · Cited by 241
Hepatic macrophages: Key players in the development and progression of liver fibrosis
Cheng, D., Chai, J., Wang, H., Fu, L., Peng, S., & Ni, X. (2021) · Liver International · doi:10.1111/liv.14940 · Cited by 188
Li, X., Jin, Q., Yao, Q., Xu, B., Li, L., Zhang, S., & Tu, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00072 · Cited by 171
“Recent data have suggested that Notch1 signaling was widely known as a key transcription factor related to M1 macrophage activation (Lawrence and Natoli, 2011; Bansal et al., 2015; Xu et al., 2015a).”
Background
Metadata
- Authors
- Bansal, R., van Baarlen, J., Storm, G., & Prakash, J.
- Affiliations
- University of Twente (NL)
- Utrecht University (NL)
- Corresponding author
- Bansal, Ruchi
- Prakash, Jai
- Venue
- Scientific Reports
- Published
- 2015-12-14
- Volume
- 5
- Issue
- 1
- Pages
- 18272-18272
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4677309
- OpenAlex
- W2375249898
- Cited by
- 107
- References
- 42
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 10 · 2023: 12 · 2022: 7 · 2021: 12 · 2020: 7 · 2019: 8 · 2018: 13 · 2017: 8 · 2016: 6
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- University of Twente Research Information (submittedVersion, cc-by)
- Funders
- University of Twente
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- Notch signaling, hepatic stellate cells, liver fibrosis, macrophage polarization, M1/M2 macrophages, gamma-secretase inhibitors, TGF-beta, hepatic stellate cell activation, CCl4-induced fibrosis, fibroblast activation, nitric oxide
- MeSH terms
- Animals, Cell Communication, Cell Differentiation, Cell Line, Disease Models, Animal, Fibroblasts, Humans, Liver Cirrhosis, Macrophage Activation, Macrophages, Oxadiazoles, Sulfonamides, Signal Transduction, Transforming Growth Factor beta, 3T3 Cells, Mice, Receptors, Notch, Hepatic Stellate Cells, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.